<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108891-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Development of a New Viral Vaccine Production Platform in Vietnam</narrative>
   <narrative xml:lang="FR">D&#xE9;veloppement d&#x2019;une nouvelle plateforme de production de vaccins viraux au Vietnam</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Avian influenza (AI) and Newcastle disease (ND) are the most prevalent poultry diseases in many Asian countries, with significant economic impact on smallholder livestock farmers. The first AI outbreak in Vietnam (at the end of 2003) resulted in the deaths of 11 people and an estimated 44 million chickens (nearly 17% of the total poultry industry). ND is the second most prevalent poultry disease in Vietnam, causing significant economic losses for the poultry industry, especially in highland and rural areas. Although efforts at vaccination have been conducted with imported and domestic vaccines, the disease is still prevalent due to low vaccination coverage. 

AI vaccines are abundant, but the highly mutable virus means that most vaccines quickly become ineffective. Additionally, most imported vaccines are not readily used in rural areas due to high cost. The Vietnam National Veterinary Joint Stock Company (NAVETCO) has successfully developed several vaccines for the local market, including vaccines for AI and ND, but they are produced using egg-based technology, which involves large quantities of sterile embryonated eggs and an expensive egg waste management system. 

To meet the demand for more effective, affordable, and environmentally friendly technologies, this project will develop cell-based technology for AI and ND vaccine production. This is expected to make vaccine production easier and more cost-effective, resulting in more affordable vaccines for smallholder poultry farmers in Vietnam.

This project is funded by the Livestock Vaccine Innovation Fund, a partnership of the Bill and Melinda Gates Foundation, Global Affairs Canada, and IDRC. It represents a joint investment of CA$57 million over five years to support the development, production, and commercialization of innovative vaccines against priority livestock diseases in sub-Saharan Africa, South Asia, and Southeast Asia.</narrative>
   <narrative xml:lang="FR">La grippe aviaire et la maladie de Newcastle (MN) sont les maladies de la volaille les plus r&#xE9;pandues dans bon nombre de pays asiatiques; celles-ci ont des r&#xE9;percussions &#xE9;conomiques importantes sur les petits &#xE9;leveurs. La premi&#xE8;re &#xE9;closion de la grippe aviaire (&#xE0; la fin de 2003) a entra&#xEE;n&#xE9; le d&#xE9;c&#xE8;s de 11 personnes et d&#x2019;environ 44 millions de poulets (pr&#xE8;s de 17 % de l&#x2019;ensemble de l&#x2019;industrie avicole). Quant &#xE0; la MN, elle arrive au deuxi&#xE8;me rang des maladies de la volaille les plus r&#xE9;pandues au Vietnam, et cause des pertes &#xE9;conomiques importantes pour l&#x2019;industrie avicole, surtout dans les hautes terres et les r&#xE9;gions rurales. M&#xEA;me si des efforts de vaccination ont &#xE9;t&#xE9; d&#xE9;ploy&#xE9;s au moyen de vaccins import&#xE9;s et nationaux, la maladie est toujours r&#xE9;pandue en raison de la faible couverture vaccinale. 

M&#xEA;me si l&#x2019;on retrouve de nombreux vaccins contre la grippe aviaire, le fait que les virus sont hautement mutables signifie que la plupart des vaccins deviennent rapidement inefficaces. De plus, la plupart des vaccins import&#xE9;s ne sont pas ais&#xE9;ment utilis&#xE9;s dans les r&#xE9;gions rurales en raison de leur co&#xFB;t &#xE9;lev&#xE9;. La Vietnam National Veterinary Joint Stock Company (NAVETCO) a r&#xE9;ussi &#xE0; &#xE9;laborer plusieurs vaccins pour le march&#xE9; local, y compris des vaccins contre la grippe aviaire et la MN. Toutefois, ces vaccins sont produits &#xE0; l&#x2019;aide d&#x2019;une technologie &#xE0; base d&#x2019;oeufs, ce qui implique l&#x2019;utilisation de grandes quantit&#xE9;s d&#x2019;&#x153;ufs embryonn&#xE9;s st&#xE9;riles et d&#x2019;un syst&#xE8;me dispendieux de gestion des d&#xE9;chets d&#x2019;&#x153;ufs. 

Afin de r&#xE9;pondre &#xE0; la demande de technologies plus efficaces, abordables et respectueuses de l&#x2019;environnement, ce projet &#xE9;laborera une technologie de culture cellulaire pour la production de vaccins contre la grippe aviaire et la MN. On s&#x2019;attend &#xE0; ce que cela rende la production de vaccins plus facile et rentable, ce qui se traduira par des vaccins plus abordables pour les petits aviculteurs du Vietnam.

Ce projet est financ&#xE9; par le Fonds d&#x2019;innovation en vaccins pour le b&#xE9;tail (FIVB), un partenariat entre la Fondation Bill et Melinda Gates, Affaires mondiales Canada et le CRDI. Cela repr&#xE9;sente un investissement conjoint de 57 millions de dollars canadiens sur cinq ans pour soutenir la conception, la production et la commercialisation de vaccins novateurs contre les maladies prioritaires qui touchent les animaux d&#x2019;&#xE9;levage en Afrique subsaharienne, en Asie du Sud et en Asie du Sud-Est.</narrative>
  </description>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
   <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="15">
   <narrative xml:lang="EN">National Veterinary Joint Stock Company</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">National Veterinary Joint Stock Company</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2019-03-01" type="2"></activity-date>
  <activity-date iso-date="2019-04-02" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="VN" percentage="100"></recipient-country>
  <sector code="2" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Increasing food security</narrative>
   <narrative xml:lang="FR">S&#xE9;curit&#xE9; alimentaire</narrative>
  </sector>
  <sector code="31182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-15"></transaction-date>
   <value currency="CAD" value-date="2019-03-15">-627622.89</value>
   <provider-org>
    <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Joint Stock Company</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-15"></transaction-date>
   <value currency="CAD" value-date="2019-03-15">627622.89</value>
   <provider-org>
    <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Joint Stock Company</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-15"></transaction-date>
   <value currency="CAD" value-date="2019-03-15">-325725.25</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
    <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Joint Stock Company</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-15"></transaction-date>
   <value currency="CAD" value-date="2019-03-15">325725.25</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
    <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Joint Stock Company</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-15"></transaction-date>
   <value currency="CAD" value-date="2019-03-15">-233451.86</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Joint Stock Company</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-03-15"></transaction-date>
   <value currency="CAD" value-date="2019-03-15">233451.86</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Joint Stock Company</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
